Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune and transcriptional responses to Fluad in healthy young children and adults
2015-001648-12Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of Fluzone Trivalent in influenza (2 arms), sponsored by University of Oxford. Primary endpoint: Differential gene expression response to priming and boosting with ATIV and correlation with HAI titers. Started Jun 2015; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2015-001648-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001648-12.